Home/Filings/4/0001562180-23-002688
4//SEC Filing

Wei Lin 4

Accession 0001562180-23-002688

CIK 0001860782other

Filed

Mar 8, 7:00 PM ET

Accepted

Mar 9, 9:48 PM ET

Size

7.2 KB

Accession

0001562180-23-002688

Insider Transaction Report

Form 4
Period: 2023-03-07
Wei Lin
Director
Transactions
  • Award

    Stock Option (Right to buy)

    2023-03-07+33,40033,400 total
    Exercise: $10.91Exp: 2033-03-07Common Stock (33,400 underlying)
  • Award

    Common Stock

    2023-03-07+16,60016,600 total
Footnotes (2)
  • [F1]This restricted stock unit award vests ratably over three years in annual installments with the first installment vesting on March 7, 2024, subject to the Reporting Person's continued service through the applicable vesting date.
  • [F2]This stock option vests ratably over three years in annual installments with the first installment vesting on March 7, 2024, subject to the Reporting Person's continued service through the applicable vesting date.

Issuer

2seventy bio, Inc.

CIK 0001860782

Entity typeother

Related Parties

1
  • filerCIK 0001872772

Filing Metadata

Form type
4
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 9:48 PM ET
Size
7.2 KB